Certara today announced the launch of its industry-leading Phoenix 8.0 PK/PD modeling and simulation software for drug development scientists.

Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.

Certara the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced that its Simcyp physiologically-based pharmacokinetic (PBPK) ...

GastroPlus, which is its simulation platform for modeling drug absorption and distribution, continues to be the flagship product. In fact, it remains its largest revenue vertical, and in Q3 2025 ...

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables Nov. 13, 2024 8:30 AM ET Simulations Plus, Inc. (SLP) ...

NEW YORK, May 09, 2025--QuantHealth, an AI-powered clinical trial simulation company, today unveiled its Large Real-World Drug Model (LRDM v1.0), a first-of-its-kind clinical trial foundation ...

A 2021 CBO working paper described a flexible simulation model, subsequently in 2023 CBO solicited input, received feedback from Congress, and in 2024 released an updated model.

At a Glance Computational modeling & simulation is another tool in the engineer's testing toolbox, says MD&M West speaker Mark Burchnall. MD&M West will be held February 4-6, 2025. Burchnall, an ...

XPS is a state-of-the-art Discrete Element Method (DEM) simulation software, developed by RCPE and distributed globally by InSilicoTrials through an exclusive partnership agreement. It is renowned ...

Dr. Silva Ryan, with assistance from scientists at Simulations Plus, will coordinate the contract’s modeling and simulation activities.